celecoxib has been researched along with Experimental Hepatoma in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Both low COX-2 expressing PLC/PRF/5 and high COX-2 expressing HuH7 cells, and nude mice bearing hepatocellular carcinoma xenografts were used to study the effect and mechanisms of celecoxib on hepatocellular carcinoma cell growth." | 7.73 | In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells. ( Cui, W; Hu, KQ; Yu, CH, 2005) |
| "Epirubicin is a chemotherapy agent for hepatocellular carcinoma (HCC)." | 3.88 | Celecoxib enhances the therapeutic efficacy of epirubicin for Novikoff hepatoma in rats. ( Chan, HH; Chang, YC; Chen, YA; Chu, TH; Hu, TH; Huang, SC; Ma, YL; Tai, MH; Wang, EM; Wen, ZH; Weng, WT; Wu, DC; Wu, JC, 2018) |
| "To validate the efficacy of an innovative multimodality therapy with transcatheter arterial embolization (TAE) plus octreotide and celecoxib in reducing neoangiogenesis and prolonging the survival of rabbits with hepatocellular carcinoma." | 3.79 | Transcatheter arterial embolization followed by octreotide and celecoxib synergistically prolongs survival of rabbits with hepatic VX2 allografts. ( Fu, P; Gao, JH; Huang, ZY; Li, X; Tang, CW; Tong, H; Wen, FQ; Wen, SL; Zhang, CL, 2013) |
| "Both low COX-2 expressing PLC/PRF/5 and high COX-2 expressing HuH7 cells, and nude mice bearing hepatocellular carcinoma xenografts were used to study the effect and mechanisms of celecoxib on hepatocellular carcinoma cell growth." | 3.73 | In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells. ( Cui, W; Hu, KQ; Yu, CH, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, TH | 1 |
| Chan, HH | 1 |
| Hu, TH | 1 |
| Wang, EM | 1 |
| Ma, YL | 1 |
| Huang, SC | 1 |
| Wu, JC | 1 |
| Chang, YC | 1 |
| Weng, WT | 1 |
| Wen, ZH | 1 |
| Wu, DC | 1 |
| Chen, YA | 1 |
| Tai, MH | 1 |
| Xu, DH | 1 |
| Chen, L | 1 |
| Tang, CW | 2 |
| Wang, CH | 1 |
| Meng, WT | 1 |
| Salcido-Neyoy, ME | 2 |
| Sierra-Santoyo, A | 1 |
| Beltrán-Ramírez, O | 2 |
| Macías-Pérez, JR | 1 |
| Villa-Treviño, S | 3 |
| Arellanes-Robledo, J | 1 |
| Márquez-Quiñones, A | 1 |
| García-Román, R | 1 |
| Le Berre, V | 1 |
| Sokol, S | 1 |
| François, JM | 1 |
| Yin, J | 1 |
| Liu, B | 1 |
| Li, B | 1 |
| Liu, Z | 1 |
| Xie, X | 1 |
| Lv, Z | 1 |
| Gao, S | 1 |
| Guang, J | 1 |
| Tong, H | 1 |
| Li, X | 1 |
| Zhang, CL | 1 |
| Gao, JH | 1 |
| Wen, SL | 1 |
| Huang, ZY | 1 |
| Wen, FQ | 1 |
| Fu, P | 1 |
| Márquez-Rosado, L | 1 |
| Trejo-Solís, MC | 1 |
| García-Cuéllar, CM | 1 |
| Cui, W | 1 |
| Yu, CH | 1 |
| Hu, KQ | 1 |
8 other studies available for celecoxib and Experimental Hepatoma
| Article | Year |
|---|---|
Celecoxib enhances the therapeutic efficacy of epirubicin for Novikoff hepatoma in rats.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Biomarkers; Carcinoma, Hepatocellular; Celecoxib; C | 2018 |
[Effect of cyclooxygenase-2 inhibitor on CD4+ CD25+ regulatory T cells in mouse hepatocellular carcinoma].
Topics: Animals; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Forkhead Transcription Factors; L | 2013 |
Celecoxib enhances the detoxification of diethylnitrosamine in rat liver cancer.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Celecoxib; Cyclooxygenase Inhibitors; Diethylnitrosamine; Li | 2009 |
Celecoxib activates Stat5 and restores or increases the expression of growth hormone-regulated genes in hepatocarcinogenesis.
Topics: Alpha-Globulins; Animals; Antineoplastic Agents; Aryl Hydrocarbon Hydroxylases; Celecoxib; Cytochrom | 2010 |
The cyclooxygenase-2 inhibitor celecoxib attenuates hepatocellular carcinoma growth and c-Met expression in an orthotopic mouse model.
Topics: Animals; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Celecoxib; Cell Proliferation; Cycl | 2011 |
Transcatheter arterial embolization followed by octreotide and celecoxib synergistically prolongs survival of rabbits with hepatic VX2 allografts.
Topics: Abdominal Neoplasms; Analysis of Variance; Animals; Antineoplastic Combined Chemotherapy Protocols; | 2013 |
Celecoxib, a cyclooxygenase-2 inhibitor, prevents induction of liver preneoplastic lesions in rats.
Topics: Animals; Celecoxib; Cyclooxygenase Inhibitors; Liver Neoplasms; Liver Neoplasms, Experimental; Male; | 2005 |
In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Celecoxib; Cell Cycle; Cell Line, Tumor; Cell Prolife | 2005 |